For the purpose of establishing a traveller’s vaccination status, the Australian government recognised Bharat Biotech’s Coronavirus vaccine Covaxin.
Australia’s High Commissioner to India, Barry O’Farrell AO tweeted “Today, the @TGAgovau determined that Covaxin (manufactured by @BharatBiotech) vaccine would be ‘recognised’ for the purpose of establishing a traveller’s vaccination status. Importantly, recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by @AstraZenecaIn), means that many Indian citizens, as well as other countries, will now be considered fully vaccinated on entry to Australia.”
Though administered to over 12 crore Indians, the indigenous vaccine is facing delays in WHO’s emergency approval. As a result, the Covaxin beneficiaries have missed out on opportunities to travel to European Union and the US.
Apart from Australia, countries that have approved Covaxin are Nepal, Mauritius, Oman, the Philippines, Iran, Sri Lanka, Mexico, Greece, Estonia and Zimbabwe.
Pic Courtesy – Google
- India Abstains on UN Resolution That Condemns Russian Invasion of Ukraine, explains move
- Oscars 2023: RRR, Black Panther: Wakanda Forever and more shortlisted for 95th Academy Awards
- Netflix Loses 200,000 Subscribers In Less Than 100 Days
- Taliban Takeover: Two Air India Aircraft On Standby For Emergency Evacuation